Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?-Reference-Cited by-同舟云学术

Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?

Published:2009-05-08 Issue:6 Volume:5 Page:607-620
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Agúndez José AG,García-Martín Elena,Martínez Carmen

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425250902970998

Reference99 articles.

1. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis

2. Nonselective Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Gastrointestinal Bleeding: Relative and Absolute Risk Estimates From Recent Epidemiologic Studies

3. Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Common genetic variants associated with urinary phthalate levels in children: A genome-wide study;Environment International;2024-08

2. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications;International Journal of Molecular Sciences;2024-04-12

3. EIDD-1931 Treatment Tweaks CYP3A4 and CYP2C8 in Arthritic Rats to Expedite Drug Interaction: Implication in Oral Therapy of Molnupiravir;ACS Omega;2024-03-15

4. Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone;PAIN Reports;2023-10-17

5. Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations;Frontiers in Pharmacology;2023-08-11